Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MMC

What Ten Days of Festival Prasad, Fasting and Late Nights Do to Your Gut and Digestion

When You Eat Matters as Much as What You EatYour stomach produces acid on a roughly four-hour cycle, anticipating food at the times your body has learned to expect it. During a ten-day festival, that rhythm collapses. Breakfast gets skipped for the morning puja. Lunch is pushed to 3 pm…

Times Life

Microsoft is updating even more parts of the Windows 11 UI with modern designs: Here's what's next on the list of overhauls

Everything from the Start menu to legacy File Explorer dialogs are being rewritten with WinUI in the coming months. This is what to expect.

Windows Central

Registration of homoeopaths: HC orders Maharashtra resident doctors to call off stir immediately

Bombay High Court ordered resident doctors to immediately end their strike. The court expressed concern over the protest's impact on numerous hospital patients. Resident doctors subsequently assured the court that their strike would be called off. The court warned of wage stoppage if doctors failed to resume their duties. The…

The Economic Times

From analysis to the latest developments in health,
read the most diverse news in one place.

For the first time, Maharashtra lets homeopathy doctors prescribe modern medicines; IMA calls strike, warns of bigger agitation

Maharashtra has made a groundbreaking decision, permitting homeopathy practitioners to prescribe conventional medicines after completing a designated training program. This change has sparked widespread protests by medical associations, voicing their worries about patient safety and medical standards. Conversely, homeopathic doctors view this as a long-sought achievement. The Maharashtra Medical Council…

The Economic Times

Is Aon Stock Underperforming the Nasdaq?

Aon has considerably underperformed the Nasdaq recently, yet analysts remain moderately optimistic about the stock’s prospects.

Barchart

Is Arthur J. Gallagher Stock Underperforming the Nasdaq?

Despite Arthur J. Gallagher's weak performance relative to the broader Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Earnings Preview: What To Expect From Marsh & McLennan's Report

Marsh & McLennan is set to deliver its fourth-quarter results soon, and analysts project single-digit earnings growth.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Marsh & McLennan Stock: Is MMC Underperforming the Financial Sector?

Marsh & McLennan has significantly underperformed the broader financial sector over the past year, and analysts remain cautiously bullish about the stock’s prospects.

Barchart

Marsh & McLennan Stock Outlook: Is Wall Street Bullish or Bearish?

Marsh & McLennan has considerably underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

Barchart

eMMC vs. SSD storage: What was the difference, and does it matter now?

Storage in a laptop is a big deal. How did eMMC storage compare to an SSD? Here's why it mattered back then but has mostly become a non-issue.

Windows Central

Marsh McLennan And Bloomberg Unite To Guide Businesses Through Global Turbulence

Marsh McLennan Companies, Inc. (NYSE:MMC) has formed a strategic knowledge partnership with Bloomberg Media to power select marquee Bloomberg events, including the New Economy Forum, Qatar Economic Forum, and Bloomberg House at Davos.

Benzinga

Marsh & McLennan Targets $400 Million In Savings With AI Driven Efficiency Push

Marsh McLennan Companies, Inc. (NYSE:MMC) reported better-than-expected third-quarter performance, driven by higher consulting revenue and continued margin resilience.

Benzinga

Marsh & McLennan Analysts Slash Their Forecasts Following Q3 Earnings

Marsh McLennan Companies Inc (NYSE:MMC) reported better-than-expected earnings for the third quarter on Thursday.

Benzinga

Marsh & McLennan's Quarterly Earnings Preview: What You Need to Know

Marsh & McLennan is gearing up to release its third-quarter results in the upcoming month, and analysts expect a solid double-digit growth in earnings.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Is Marsh & McLennan Stock Underperforming the Dow?

Marsh & McLennan has significantly underperformed the Dow over the past year, and analysts remain cautious about the stock’s prospects.

Evening Standard

Who are the Maniacs Murder Cult and the Russian Imperial Movement set to be proscribed with Palestine Action

The UK plans to proscribe Palestine Action alongside the Maniacs Murder Cult and the Russian Imperial Movement

The Guardian - UK

Why is Palestine Action being banned and what happens next?

Formal process for proscribing group has begun – and if a legal challenge fails, it will be banned on Saturday

Barchart

Marsh & McLennan Companies’ Q2 2025 Earnings: What to Expect

Marsh & McLennan Companies is set to unveil its second-quarter results in the next month, and analysts expect a double-digit growth in earnings.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Is Marsh & McLennan Stock Underperforming the Nasdaq?

Marsh & McLennan has underperformed the Nasdaq over the past year, and analysts are cautious about the stock’s prospects.

Digital Camera World

Happy 25th birthday to the SD card! The memory format that refuses to die

It's easily the most successful memory card format ever and shows little sign of being overtaken

Barchart

Is Wall Street Bullish or Bearish on Marsh & McLennan Stock?

Marsh & McLennan has underperformed the broader market over the past year and analysts remain skeptical about its long-term prospects.

Barchart

Marsh & McLennan Earnings Preview: What to Expect

Marsh & McLennan will release its first-quarter earnings this month, and analysts anticipate a single-digit bottom-line growth.

Barchart

Is Willis Towers Watson Stock Outperforming the Dow?

As Willis Towers Watson has outpaced the Dow recently, analysts remain moderately optimistic about the stock’s prospects.

Barchart

Is Marsh & McLennan Stock Outperforming the S&P 500?

Marsh & McLennan has exceeded the broader S&P Index’s performance over the past year, but analysts remain cautious about the stock’s prospects.

Barchart

Are Wall Street Analysts Bullish on Marsh & McLennan Stock?

Due to Marsh & McLennan’s underperformance relative to the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.